Aletheian Wealth Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$312K Buy
2,428
+436
+22% +$51K 0.13% 83
2026
Q1
$240K Buy
+1,992
New +$230K 0.12% 84
2025
Q3
$202K Buy
+2,401
New +$198K 0.09% 98
2025
Q2
Sell
-2,614
Closed -$235K 102
2025
Q1
$235K Buy
+2,614
New +$244K 0.13% 82
2024
Q4
Sell
-2,080
Closed -$236K 83
2024
Q3
$236K Sell
2,080
-348
-14% -$41.3K 0.14% 73
2024
Q2
$301K Buy
2,428
+332
+16% +$42.8K 0.16% 73
2024
Q1
$277K Buy
+2,096
New +$258K 0.15% 72
2023
Q3
Sell
-1,930
Closed -$223K 79
2023
Q2
$223K Buy
+1,930
New +$219K 0.15% 76

Other funds holding MRK

Aletheian Wealth Advisors's MRK Position: Q2 2026 in Review

Aletheian Wealth Advisors increased its Merck (MRK) stake by 22% in Q2 2026, buying an estimated $51K and bringing the position to 2,428 shares worth $312K. The position accounts for 0.13% of the portfolio, ranked #83.

Aletheian Wealth Advisors first reported a position in MRK in Q2 2023 and has held it in 8 quarters since. 1,165 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Aletheian Wealth Advisors held 2,428 shares of Merck worth $312K as of Q2 2026.
  • Aletheian Wealth Advisors bought 436 Merck shares in Q2 2026, an estimated $51K.
  • Merck made up 0.13% of Aletheian Wealth Advisors's portfolio in Q2 2026, its #83 holding.
  • Aletheian Wealth Advisors first reported a position in Merck in Q2 2023 and has held it in 8 quarters since.
  • 1,165 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Aletheian Wealth Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.